External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Rheumatology Rheumatoid Arthritis

Rheumatoid Arthritis

What's new

Sign up or login to unlock the full suite of MEDICALLY features
Independent content
Jun 23 / Springer Healthcare
EULAR 2021 in-depth report: Rheumatoid arthritis and rheumatic diseases
This in-depth report provides an overview of the management and pathobiology of rheumatoid arthritis, including an update on EULAR recommendations.
Rheumatology Rheumatoid Arthritis
Bookmark this
Share page

Sign up or login to unlock the full suite of MEDICALLY features
May 14 / Roche and Genentech
Listen to Dr. Khanna speak about Preservation of Lung Function With Tocilizumab in Patients With Systemic Sclerosis Interstitial Lung Disease: Analysis From the Double-Blind Period of a Phase 3 Trial
Post hoc analysis of patients from the double-blind period of the phase 3 randomized controlled focuSSced trial who had evidence of interstitial lung disease at baseline showed that early identification of interstitial lung disease and initiation of tocilizumab treatment may help preserve lung function in patients with systemic sclerosis-associated interstitial lung disease and elevated inflammatory markers.
Rheumatology Rheumatoid Arthritis ATS-2021

Sign up or login to unlock the full suite of MEDICALLY features
May 14 / Roche and Genentech
Listen to Dr. Khana speak about Tocilizumab in Systemic Sclerosis Interstitial Lung Disease: Safety and Efficacy in the Double-Blind and Open-Label Periods of a Randomized Controlled Phase 3 Trial
Lung function was preserved in patients with systemic sclerosis-associated interstitial lung disease who were treated with tocilizumab for 96 weeks continuously and in those who started tocilizumab treatment after 48 weeks in the focuSSced phase 3 randomized controlled trial and long term extension.
Rheumatology Rheumatoid Arthritis ATS-2021
Upcoming Congresses
Access to Roche and Genentech’s latest medical information
View related congresses

Ask a question or share feedback

Get in touch

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.